Web-Based System Developed to Give Care Homes Simple Access to COVID-19 Tests

CliniSys GroupBlack Country Pathology Services has worked with CliniSys to create the ICE Portal, a web-based application that makes it easy for care homes, or other community care settings, to be able to order lab based COVID-19 tests and see the results.

The pathology network has also drawn up plans with the company to continue development work on the ICE Portal, so it is ready for future health emergencies and can be used by other health and care services that need to order tests but can’t use existing networks and IT systems.

Programme manager Manx Baker explained: "When the pandemic arrived, it soon became apparent that pathology services across the country were not set-up to test people who are being cared for outside our family of NHS services.

"We called CliniSys and said: 'We need a website that care homes can use to order tests that sends the details straight into our systems' - and we worked in partnership with them to create the ICE Portal.

"Although the pandemic is reducing in the UK, we will continue to develop the portal as an important piece of testing infrastructure that we just did not have before the crisis.

"We will also look to extend the portal so it can be used by other services that need to order tests from outside our normal systems, such as sexual health services and the primary care Vitamin D testing service."

Black Country Pathology Services is a major pathology network that provides laboratory services to four large acute trusts from its base in Wolverhampton, where it has built a state-of-the-art hub for microbiology, histopathology and blood sciences.

The network is an exemplar for the use of CliniSys systems and runs both the WinPath Enterprise laboratory information system and the Integrated Clinical Environment, or ICE.

This is used by hospital departments and GPs to order tests and receive results, but it isn’t used by care homes, which tend not to be connected to the highly secure networks over which it runs.

When the Covid-19 pandemic hit the UK last spring, NHS Wolverhampton CCG had to employ a team of administrators to enter requests into their order comms system; which was costly, time-consuming and ran the risk of transcription errors.

Black Country Pathology Services felt there had to be a better way, and worked with CliniSys, for which it is also a development partner, to create the ICE Portal as a lightweight, web-based system that is easy to use.

A nominated person at each care home just needs to log-in and create a list of patients and staff. The portal interface checks the details and associates them with a record on ICE. After that, the nominated person can order tests for any residents or staff who need them and print off a barcoded form for each one.

When the sample arrives at the lab, the barcode is scanned so the test tube can be matched to the details that are already in the system. On completion of the test, the results are sent back to the ICE Portal and viewed by individuals with appropriate permission.

Senior ICT programme manager Nick Fudger added: "The ICE Portal is something that has been a positive of COVID-19.

"It will be hugely beneficial if we ever face a similar crisis, and it is something that can be scaled for other services once the current pandemic is over. It is a really good piece of work that we want to use as widely as possible in the future."

ICE product director Darren Solomon said CliniSys had been delighted to be involved in the project. "In the face of adversity, Black Country Pathology Services decided to work both harder and smarter and to try to deliver a better service to the people who needed them," he said.

"It was a really great piece of practical thinking, and what started out as a concept in Q3 2020, became a reality in Q1 2021. We are now focused on how we extend and evolve the ICE Portal, and are committed to working with both Black Country Pathology Services and our other customers on innovative workflows that can be supported by our new product."

About CliniSys Group

CliniSys Group is the largest laboratory diagnostic IT vendor in Europe, with leading country market shares and an innovative and wide-reaching suite of end-to-end diagnostic solutions.

Headquartered in England, with local offices in six European countries, it has for more than 40 years been at the forefront of diagnostics workflow, order communications and information management solutions supporting radiology, cardiology and all pathology disciplines including anatomical or cellular, molecular and genetics.

These encompass the complete workflow from order, clinical decision support, collection, processing, analysis, results and reporting, through integration into the clinical workflow. CliniSys Group has built an unrivalled reputation for the deployment of complex diagnostics networks and academic centres - and is the only vendor repeatably delivering across all disciplines end to end - at scale.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...